Interstitial Lung Disease

What is interstitial lung disease?

Interstitial lung disease is the name for a large group of conditions that cause inflammation and scarring in the lungs. The word “interstitial” refers to the interstitium, which is the delicate network of tissue that surrounds and supports the tiny air sacs (alveoli) where oxygen passes into the blood. When this tissue becomes inflamed or thickened by scar tissue — a process doctors call fibrosis — the lungs become stiffer and less able to move oxygen into the bloodstream. In medical coding, unspecified interstitial lung disease is listed under ICD-10 code J84.9.

Rather than being a single illness, interstitial lung disease covers more than a hundred related disorders. Some develop for reasons doctors can identify, such as long-term exposure to dust, certain medicines, or autoimmune diseases, in which the body’s immune system mistakenly attacks its own tissues. Others, such as idiopathic pulmonary fibrosis, have no known cause; “idiopathic” simply means the cause is unknown.

Interstitial lung disease can affect people of any age, but many forms are more common in middle-aged and older adults. Some types appear more often in people who smoke or have smoked, people exposed to certain occupational dusts, and people living with autoimmune conditions such as rheumatoid arthritis or scleroderma. In a smaller number of families, genetic factors may play a role. Because the group of conditions is so varied, the outlook and the best approach to treatment can differ widely from one person to another, which is why an accurate diagnosis matters so much.

Symptoms of interstitial lung disease

Interstitial lung disease symptoms usually develop gradually, often over months or even years, although some forms can appear more quickly. Because the early signs are easy to mistake for aging, being out of shape, or a lingering chest infection, many people are diagnosed only after the disease has progressed. Common symptoms include:

• Shortness of breath — at first only during exertion, such as climbing stairs or walking uphill, and later sometimes even at rest.
• A dry, persistent cough that does not produce mucus and does not improve with usual cough remedies.
• Fatigue and a general feeling of low energy.
• Unintended weight loss in some people.
• Aching muscles and joints, particularly when the disease is linked to an autoimmune condition.
• Clubbing of the fingers or toes — a widening and rounding of the fingertips and nails that can develop in long-standing disease.

How symptoms behave often depends on the type and stage of the disease. In early or mild disease, a person may notice only slight breathlessness during heavy activity. As scarring progresses, everyday tasks such as dressing, showering, or talking on the phone can become tiring. In advanced disease, low oxygen levels may cause a bluish tint to the lips or fingertips, and some people develop strain on the right side of the heart, a complication called pulmonary hypertension (high blood pressure in the arteries of the lungs).

Some forms of interstitial lung disease, such as hypersensitivity pneumonitis (an allergic-type lung reaction to inhaled substances), can cause episodes of fever, chills, and cough after exposure to a trigger. Others, such as acute interstitial pneumonia, can worsen rapidly over days. Sudden or severe worsening of breathlessness, sometimes called an acute exacerbation, is a medical emergency in people who already have the condition.

Causes and risk factors

Interstitial lung disease causes fall into several broad groups, and in many cases no cause is ever found. Understanding the possible cause helps doctors choose treatment, because inflammation driven by an ongoing exposure or an autoimmune disease may respond differently than established scarring.

• Occupational and environmental exposures. Long-term inhalation of certain dusts and fibers can scar the lungs. Examples include silica dust (found in mining, stone cutting, and construction), asbestos fibers, coal dust, and metal dusts. Organic materials — such as moldy hay, bird droppings and feathers, or contaminated humidifiers — can trigger hypersensitivity pneumonitis in susceptible people.
• Autoimmune and connective tissue diseases. Conditions such as rheumatoid arthritis, scleroderma (systemic sclerosis), lupus, Sjögren’s syndrome, and inflammatory muscle diseases can involve the lungs. In some people, lung disease is the first sign of the underlying condition.
• Medications and medical treatments. Some chemotherapy drugs, certain heart rhythm medicines, some antibiotics, and radiation therapy to the chest can damage lung tissue in a small proportion of people who receive them.
• Infections. Certain viral, bacterial, and fungal infections can leave behind inflammation or scarring in the interstitium.
• Smoking. Several forms of interstitial lung disease occur mainly in people who smoke, and smoking may also worsen other forms.
• Genetics. A family history of pulmonary fibrosis modestly increases risk in some families, suggesting inherited factors can contribute.
• Unknown (idiopathic) causes. Idiopathic pulmonary fibrosis is the most common of the idiopathic forms and typically affects adults over 60, more often men and current or former smokers.

Other factors linked to a higher risk include older age, gastroesophageal reflux disease (chronic acid reflux, which some research suggests may contribute to lung injury), and prior chest radiation. Having a risk factor does not mean a person will develop interstitial lung disease; it simply means the likelihood is higher than average.

Diagnosis

Interstitial lung disease diagnosis can be complex, because many conditions produce similar symptoms and no single test confirms every type. Doctors usually combine a detailed history, physical examination, imaging, and breathing tests, and in some cases tissue sampling.

• Medical history and examination. Your doctor will ask about your work history, hobbies, exposure to birds or mold, medications, smoking, family history, and symptoms of autoimmune disease such as joint pain, dry eyes, or skin changes. Listening to the chest often reveals fine crackling sounds, sometimes described as “Velcro crackles,” which are typical of lung fibrosis.
• High-resolution CT scan (HRCT). This detailed computed tomography scan of the chest is the most important imaging test. It shows the pattern and distribution of inflammation and scarring, and specific patterns — such as “honeycombing,” which describes clusters of small cystic spaces in scarred lung — help identify the type of disease. A plain chest X-ray may show changes but is far less detailed.
• Pulmonary function tests. These breathing tests measure how much air the lungs can hold and how well oxygen passes into the blood. Interstitial lung disease typically causes a “restrictive” pattern, meaning the lungs cannot expand fully, and a reduced diffusing capacity, meaning gas transfer is impaired.
• Blood tests. Blood work can look for markers of autoimmune disease and, in some cases, antibodies related to environmental exposures.
• Oxygen measurements. A pulse oximeter (a small clip on the finger) measures blood oxygen at rest and during a six-minute walk test, which shows whether oxygen levels drop with activity.
• Bronchoscopy. In selected cases, a thin flexible tube is passed into the airways to wash out and collect cells (bronchoalveolar lavage) or to take small tissue samples. A technique called cryobiopsy can obtain larger samples through the bronchoscope.
• Surgical lung biopsy. When the diagnosis remains unclear and the result would change treatment, surgeons may remove small pieces of lung tissue through keyhole surgery for examination under a microscope. This is not needed for everyone.

In many centers, the final diagnosis is made at a multidisciplinary meeting where lung specialists, radiologists, and pathologists review all the findings together. This team approach is considered the standard of care because it improves diagnostic accuracy. Care for interstitial lung disease is typically led by a pulmonology (lung medicine) department; you can read more about this specialty at the pulmonology department page.

Treatment options

Interstitial lung disease treatment depends on the specific type, the cause when one is found, how severe the disease is, and how quickly it is progressing. Established scar tissue in the lungs generally cannot be reversed, so treatment focuses on controlling inflammation, slowing further scarring, relieving symptoms, and protecting quality of life. Your doctor may recommend one or several of the following approaches.

Removing the cause and monitoring

When a trigger can be identified — such as an occupational dust, a pet bird, mold in the home, or a medication — removing that exposure is a central part of treatment and may allow inflammation to settle. For some people with mild, stable disease, doctors may recommend a period of careful monitoring with regular breathing tests and scans rather than starting medication immediately, an approach sometimes called watchful waiting.

Medications

• Corticosteroids. Steroid tablets such as prednisone reduce inflammation and are often used for forms of the disease in which inflammation, rather than fixed scarring, is the main problem. They can have significant side effects with long-term use, so doctors aim for the lowest effective dose.
• Other immunosuppressants. Medicines that calm the immune system, such as mycophenolate or azathioprine, are used in many autoimmune-related forms of interstitial lung disease, sometimes alongside or instead of steroids.
• Antifibrotic drugs. For idiopathic pulmonary fibrosis and some other progressive fibrosing forms, medicines called antifibrotics (nintedanib and pirfenidone) can slow the rate at which lung function declines. They do not reverse existing scarring, and they have side effects that your doctor will discuss with you.
• Treatment of related conditions. Managing acid reflux, pulmonary hypertension, or an underlying autoimmune disease is often part of the overall plan.

Oxygen therapy

If blood oxygen levels are low at rest, during activity, or during sleep, supplemental oxygen delivered through a small tube under the nose can reduce breathlessness, improve exercise capacity, and help protect the heart. Oxygen does not stop the disease itself, but it can meaningfully improve daily comfort and function.

Pulmonary rehabilitation

Pulmonary rehabilitation is a structured program of supervised exercise, breathing techniques, and education. It does not change the scarring in the lungs, but in many cases it improves stamina, reduces breathlessness, and supports emotional well-being. Most people with interstitial lung disease can benefit from it at some stage.

Lung transplantation

For selected people with advanced, progressive disease that no longer responds to other treatments, lung transplantation may be considered. Transplant involves major surgery, lifelong anti-rejection medication, and careful candidate selection, so doctors usually discuss referral to a transplant program well before it becomes urgent. It is not suitable for everyone, and your care team can explain whether it is a realistic option in your situation.

Supportive and palliative care

Supportive care — including treatment of cough, breathlessness management, nutritional support, and vaccination against flu, pneumococcal disease, and COVID-19 — is important at every stage. In advanced disease, palliative care specialists can help control symptoms and support patients and families; palliative care is about comfort and quality of life and is not limited to end-of-life situations. At hospitals in the Acibadem group, this condition is managed within the pulmonology specialty, often in cooperation with rheumatology, radiology, and thoracic surgery teams.

Living with interstitial lung disease and outlook

The outlook for interstitial lung disease varies enormously depending on the type. Some inflammatory forms improve substantially, or even resolve, once the trigger is removed or treated. Others, particularly idiopathic pulmonary fibrosis, tend to progress over time despite treatment, although the pace of decline differs from person to person and modern antifibrotic medicines can slow it in many cases. No doctor can predict an individual’s course with certainty, and statistics you may read online describe averages, not your personal future.

Day to day, several steps can help you stay as well as possible:

• Do not smoke, and avoid secondhand smoke; quitting is one of the most important things a person with lung disease can do.
• Avoid known triggers such as dusts, molds, or bird exposure if these have been linked to your disease.
• Stay active within your limits; regular gentle exercise helps maintain fitness, and pulmonary rehabilitation can guide you safely.
• Keep vaccinations up to date, because chest infections can cause serious setbacks.
• Attend regular follow-up so your care team can track lung function and adjust treatment early if the disease changes.
• Eat well and maintain a healthy weight, since both undernutrition and excess weight can worsen breathlessness.
• Seek support for anxiety or low mood, which are common and treatable; patient support groups can also be valuable.

Many people live for years with interstitial lung disease, adapting their routines and continuing to work, travel, and enjoy family life, especially when the disease is diagnosed early and monitored closely.

Frequently asked questions

What is interstitial lung disease in simple terms?

It is a group of conditions in which the tissue around the lungs’ air sacs becomes inflamed or scarred. This makes the lungs stiff and reduces how well oxygen passes into the blood, which is why breathlessness and a dry cough are the most common symptoms.

Can interstitial lung disease be cured or can the lungs heal?

In some forms, especially those caused by inflammation, medication or removal of the trigger can lead to major improvement, and occasionally the lungs recover largely or completely. However, once true scar tissue (fibrosis) has formed, it generally cannot be reversed with current treatments. In those cases, the goal of treatment is to slow further scarring and manage symptoms.

How serious is interstitial lung disease?

Seriousness depends on the specific type, the amount of scarring, and how quickly it progresses. Some people have mild, stable disease for many years, while others, particularly those with idiopathic pulmonary fibrosis, experience a steadier decline. Regular monitoring helps your care team identify changes early and adjust treatment.

What are the early symptoms of interstitial lung disease?

The most common early symptoms are breathlessness during exertion — such as climbing stairs — and a persistent dry cough. Fatigue is also frequent. Because these symptoms can have many causes, they are easy to overlook, and anyone with unexplained breathlessness lasting more than a few weeks should be evaluated by a doctor.

Is interstitial lung disease the same as pulmonary fibrosis?

Not exactly. Pulmonary fibrosis means scarring of the lungs and is a feature of many, but not all, interstitial lung diseases. Idiopathic pulmonary fibrosis is one specific type of interstitial lung disease in which the cause of the scarring is unknown.

How is interstitial lung disease diagnosed?

Doctors combine your medical and exposure history with a high-resolution CT scan of the chest, breathing tests, and blood tests. In some cases, a bronchoscopy or a surgical lung biopsy is needed. The final diagnosis is often made by a team of lung specialists, radiologists, and pathologists reviewing all the results together.

Can you live a normal life with interstitial lung disease?

Many people continue their usual activities for a long time, particularly when the disease is mild or slowly progressive and well managed. Adjustments such as pacing activities, using oxygen when prescribed, joining pulmonary rehabilitation, and avoiding infections can help maintain independence and quality of life, though no outcome can be guaranteed.

When to see a doctor

See a doctor promptly if you have breathlessness that is new, unexplained, or gradually worsening, or a dry cough lasting more than a few weeks — especially if you have risk factors such as smoking, an autoimmune disease, or exposure to dusts, molds, or birds. Early evaluation gives the best chance of identifying the cause and starting appropriate treatment.

If you have already been diagnosed with interstitial lung disease, seek urgent medical attention if you notice any of the following red flags:

• Sudden or rapidly worsening shortness of breath over hours or days, which may signal an acute exacerbation or another emergency.
• Blue or gray lips, face, or fingertips, which suggests dangerously low oxygen levels.
• Chest pain or pressure, particularly if it is severe or accompanied by breathlessness.
• Coughing up blood.
• Fever with worsening cough or breathlessness, which may indicate a chest infection.
• New swelling of the ankles or legs, which can be a sign of strain on the heart.
• Confusion, extreme drowsiness, or fainting, which can accompany very low oxygen levels.

If any of these occur, treat the situation as an emergency and get medical help immediately. For ongoing concerns that are not urgent, discuss changes in your symptoms with your lung specialist at your next appointment, or sooner if your care team has advised you to report specific warning signs.